Lateral Flow Assays Market by Product (Kits, Readers), Application (Clinical Testing, Veterinary Diagnostics, Food Safety & Environmental Testing), Technique (Sandwich, Multiplex Detection Assay), End User (Hospitals, Home care) - Global Forecast to 2027
Lateral Flow Assays Market by Product (Kits, Readers), Application (Clinical Testing, Veterinary Diagnostics, Food Safety & Environmental Testing), Technique (Sandwich, Multiplex Detection Assay), End User (Hospitals, Home care) - Global Forecast to 2027
Abstract
The global lateral flow assays market is projected to reach USD 22.6 billion by 2027 from USD 20.5 billion in 2022, at a CAGR of 2.0% during the forecast period. The growth of lateral flow assay market is due to the high prevalence of infectious diseases in many countries, growing demand for point-of-care testing, and rising use of home-based lateral flow assay devices whereas reluctance among doctors and patients to change existing diagnostic procedures and the low accuracy of lateral flow assays are restraining the market.
“Urine samples accounted for the third largest share of lateral flow assays market in 2021”
Based on sample type, the clinical testing lateral flow assays market is segmented into blood, urine, saliva, and other samples. Urine samples accounted for the third largest market share in 2021. The increasing use of urine samples in lateral flow tests for pregnancy, fertility testing, and drug of abuse testing.
“The Pharmaceutical & Biotechnology Companies segment is expected to witness the fastest growth during the forecast period”
Based on end users, the lateral flow assays market is segmented into hospitals & clinics, diagnostic laboratories, home care settings, pharmaceutical & biotechnology companies, and other end users. The pharmaceutical & biotechnology companies segment is expected to witness the fastest growth during the forecast period. This growth is owing to increasing adoption of lateral flow assay readers and kits & reagents for quantitative detection of sample in pharmaceutical & biotechnology companies.
“Asia-Pacific accounted for the second largest share of the lateral flow assays market in 2021”
The North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2021, Asia-Pacific accounted for the second largest share of the lateral flow assays market, followed by Europe, Latin America, and the Middle East & Africa. However, the North America is a leading region in the lateral flow assay market. Being a high-growth market, many manufacturers are also extending their manufacturing bases in the Asia Pacific, which boasts low-cost manufacturing advantages and the availability of a skilled workforce, especially in China and India.
These countries are also regarded as the most profitable manufacturing and R&D locations across the globe. The key factors hindering market growth in this region are a lack of awareness about the advantages of near-patient testing products due to low literacy rates, lack of reimbursements, challenges related to locational remoteness, and the reluctance of physicians to change existing practices.
A breakdown of the primary participants (supply-side) for the lateral flow assays market referred to for this report is provided below:
•By Company Type: Tier 1–35%, Tier 2–20%, and Tier 3–45%
•By Designation: C-level–45%, Director Level–25%, and Others–30%
•By Region: North America–36%, Europe–26%, Asia Pacific–21%, Latin America- 10%, and Middle East and Africa– 7%
Some of the key players in the Lateral flow assays market are Abbott Laboratories (US), F. Hoffman-La Roche AG (Switzerland), Danaher Corporation (US), Siemens AG (Germany), BD (US), bioMérieux SA (France), Thermo Fisher Scientific, Inc. (US), PerkinElmer Inc. (US), Hologic Inc. (US), QIAGEN N.V. (Netherlands), Quidel Corporation (US), and Merck KGaA (Germany).
Research Coverage:
The market study covers the lateral flow assays market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by product type, application by technique, by sample type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the lateral flow assays market and its segments. This report will help stakeholders understand the competitive landscape, gain insights to position their businesses better, and plan suitable go-to-market strategies. The report will also help stakeholders in understanding the pulse of the market and gaining information on key market drivers, restraints, opportunities, and challenges.
Content
Table of Contents
1INTRODUCTION32
1.1STUDY OBJECTIVES32
1.2MARKET DEFINITION32
1.2.1INCLUSIONS AND EXCLUSIONS33
1.3MARKET SCOPE34
1.3.1MARKETS COVERED34
FIGURE 1LATERAL FLOW ASSAYS MARKET SEGMENTATION34
FIGURE 2REGIONAL SCOPE35
1.3.2YEARS CONSIDERED35
1.4CURRENCY CONSIDERED35
TABLE 1EXCHANGE RATES UTILIZED FOR CONVERSION TO USD36
1.5STAKEHOLDERS36
1.6SUMMARY OF CHANGES36
1.6.1RECESSION IMPACT37
2RESEARCH METHODOLOGY38
2.1RESEARCH APPROACH38
FIGURE 3RESEARCH DESIGN38
2.1.1SECONDARY DATA38
2.1.1.1Key data from secondary sources39
2.1.2PRIMARY DATA40
2.1.2.1Primary sources40
2.1.2.2Key data from primary sources41
2.1.2.3Breakdown of primaries41
FIGURE 4BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION41
2.2MARKET SIZE ESTIMATION42
FIGURE 5MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021)43
FIGURE 6SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAYS MARKET (2021)43
FIGURE 7APPROACH 3: DEMAND-SIDE APPROACH, BASED ON MALARIA LATERAL FLOW TESTING MARKET SIZE (2021)44
FIGURE 8TOP-DOWN APPROACH44
FIGURE 9DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022–2027): IMPACT ON MARKET GROWTH AND CAGR46
FIGURE 10CAGR PROJECTIONS46
2.3MARKET BREAKDOWN AND DATA TRIANGULATION47
FIGURE 11DATA TRIANGULATION METHODOLOGY48
2.4KEY INDUSTRY INSIGHTS49
2.5LIMITATIONS49
2.5.1METHODOLOGY-RELATED LIMITATIONS49
2.6RISK ASSESSMENT50
2.7STUDY ASSUMPTIONS50
2.8RECESSION IMPACT51
3EXECUTIVE SUMMARY52
FIGURE 12LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)52
FIGURE 13LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION)53
FIGURE 14LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)53
FIGURE 15LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2022 VS. 2027 (USD MILLION)54
FIGURE 16LATERAL FLOW ASSAYS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)55
FIGURE 17GEOGRAPHIC SNAPSHOT OF LATERAL FLOW ASSAYS MARKET56
4PREMIUM INSIGHTS57
4.1LATERAL FLOW ASSAYS MARKET OVERVIEW57
FIGURE 18HIGH PREVALENCE OF INFECTIOUS DISEASES TO DRIVE MARKET57
4.2REGIONAL MIX: LATERAL FLOW ASSAYS MARKET57
FIGURE 19ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD57
4.3ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION AND COUNTRY (2021)58
FIGURE 20CLINICAL TESTING SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 202158
4.4LATERAL FLOW ASSAYS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES59
FIGURE 21CHINA TO REGISTER HIGHEST GROWTH IN FORECAST PERIOD59
4.5LATERAL FLOW ASSAYS MARKET: DEVELOPING VS. DEVELOPED COUNTRIES60
FIGURE 22DEVELOPING COUNTRIES TO OFFER HIGH GROWTH OPPORTUNITIES IN FORECAST PERIOD60
5MARKET OVERVIEW61
5.1INTRODUCTION61
5.2MARKET DYNAMICS61
FIGURE 23LATERAL FLOW ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES61
5.2.1DRIVERS62
5.2.1.1High prevalence of infectious diseases62
TABLE 2PREVALENCE OF HIV WORLDWIDE (2017 VS. 2021)62
5.2.1.2Rapidly increasing geriatric population63
FIGURE 24GERIATRIC POPULATION, BY REGION, 2020 VS. 2050 (MILLION)63
FIGURE 25GERIATRIC POPULATION, BY REGION, 2022 VS. 2030 VS. 2050 (% OF TOTAL POPULATION)64
5.2.1.3Growing use of home-based lateral flow assay devices64
5.2.1.4Growing demand for point-of-care testing65
5.2.1.5Need for rapid diagnostic testing for COVID-1965
5.2.2RESTRAINTS66
5.2.2.1Inconsistent results of lateral flow assay tests66
5.2.3OPPORTUNITIES66
5.2.3.1Evolving applications of lateral flow assays66
TABLE 3LIST OF COMMERCIALLY AVAILABLE SALIVA LFA PRODUCTS67
5.2.3.2Rising demand for lateral flow assays in food & beverage industry67
5.2.3.3Omicron offers growth opportunities for players in lateral flow assays market68
TABLE 4EPIDEMIOLOGICAL UPDATE ON OMICRON VARIANT68
TABLE 5EXAMPLES OF LATERAL FLOW ASSAY KITS AVAILABLE FOR DETECTION OF OMICRON68
5.2.4CHALLENGES69
5.2.4.1Limited reimbursements for lateral flow assay products69
5.2.4.2Difficulties in procuring quality raw materials for development of lateral flow assay tests70
5.3COVID-19 IMPACT ASSESSMENT ON ECONOMIC SCENARIO70
5.4TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS70
FIGURE 26TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS71
5.5AVERAGE SELLING PRICE TREND71
5.5.1AVERAGE SELLING PRICES OF KEY PLAYERS, BY APPLICATION71
TABLE 6AVERAGE SELLING PRICE OF LATERAL FLOW ASSAYS (KITS AND REAGENTS)71
5.5.2AVERAGE SELLING PRICE TRENDS72
TABLE 7AVERAGE SELLING PRICE OF LATERAL FLOW ANALYZERS, BY REGION, 2020 VS. 202172
5.6ECOSYSTEM MARKET MAP72
FIGURE 27LATERAL FLOW ASSAYS MARKET: ECOSYSTEM ANALYSIS (2021)73
5.7PATENT ANALYSIS74
5.7.1PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS74
FIGURE 28GLOBAL PATENT PUBLICATION TRENDS IN LATERAL FLOW ASSAYS MARKET, 2016–202274
5.7.2TOP APPLICANTS (COMPANIES) OF LATERAL FLOW ASSAY PATENTS75
FIGURE 29TOP COMPANIES THAT APPLIED FOR LATERAL FLOW ASSAY PATENTS, 2016–202275
5.7.3JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN LATERAL FLOW ASSAYS MARKET75
FIGURE 30JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAY PATENTS, 2016–202275
5.8VALUE CHAIN ANALYSIS76
FIGURE 31LATERAL FLOW ASSAYS MARKET: VALUE CHAIN ANALYSIS (2021)76
5.9TECHNOLOGY ANALYSIS76
5.9.1KEY TECHNOLOGY: LATERAL FLOW ASSAYS76
5.9.2ADJACENT TECHNOLOGY: ENZYME-LINKED IMMUNOSORBENT ASSAYS77
5.10CASE STUDY ANALYSIS77
5.11REGULATORY ANALYSIS78
5.11.1REGULATORY LANDSCAPE78
5.11.1.1North America78
5.11.1.2Europe78
5.11.1.3Asia79
5.11.1.3.1India79
5.11.1.3.2China79
5.11.1.3.3Japan79
5.11.2REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS80
TABLE 8REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY BY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS80
5.12PORTER’S FIVE FORCES ANALYSIS80
TABLE 9LATERAL FLOW ASSAYS MARKET: PORTER’S FIVE FORCES ANALYSIS80
5.12.1THREAT OF NEW ENTRANTS81
5.12.2THREAT OF SUBSTITUTES81
5.12.3BARGAINING POWER OF SUPPLIERS82
5.12.4BARGAINING POWER OF BUYERS82
5.12.5INTENSITY OF COMPETITIVE RIVALRY82
5.13ADJACENT MARKET ANALYSIS82
5.14KEY CONFERENCES AND EVENTS DURING 2023–202483
TABLE 10LATERAL FLOW ASSAYS MARKET: DETAILED LIST OF CONFERENCES & EVENTS83
5.15KEY STAKEHOLDERS AND BUYING CRITERIA84
5.15.1KEY STAKEHOLDERS IN BUYING PROCESS84
FIGURE 32INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS84
TABLE 11INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS84
5.15.2BUYING CRITERIA84
FIGURE 33KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS84
5.16TRADE ANALYSIS85
5.17INDUSTRY TRENDS85
5.17.1DETECTION OF HIV WITH LATERAL FLOW ASSAYS85
TABLE 12US: HIV PREVALENCE RATE, 2016–202085
5.17.2INCREASING ADOPTION OF QUANTITATIVE LATERAL FLOW ASSAYS DUE TO AVAILABILITY OF LFA READERS86
5.18IMPACT OF INFLATION AND RECESSION ON LATERAL FLOW ASSAYS MARKET86
6LATERAL FLOW ASSAYS MARKET, BY PRODUCT88
6.1INTRODUCTION89
TABLE 13LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)89
6.2KITS AND REAGENTS89
6.2.1INCREASING DEMAND FOR POC TESTING TO DRIVE MARKET89
TABLE 14LATERAL FLOW KITS AND REAGENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)90
6.3LATERAL FLOW READERS90
TABLE 15EXAMPLES OF LATERAL FLOW READERS AVAILABLE IN MARKET91
TABLE 16LATERAL FLOW ASSAY KITS AND REAGENTS WITH AND WITHOUT ANALYZERS92
TABLE 17LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION)93
TABLE 18LATERAL FLOW READERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)93
TABLE 19LATERAL FLOW READERS MARKET, BY END USER, 2020–2027 (USD MILLION)93
TABLE 20LATERAL FLOW READERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)94
6.3.1DIGITAL/HANDHELD READERS94
6.3.1.1Technological advancements and high accuracy—major factors driving market94
TABLE 21DIGITAL/HANDHELD LATERAL FLOW READERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)95
TABLE 22DIGITAL/HANDHELD LATERAL FLOW READERS MARKET, BY REGION, 2020–2027 (THOUSAND UNITS)96
6.3.2BENCHTOP READERS96
6.3.2.1Lower diagnosis cost per patient to drive adoption96
TABLE 23BENCHTOP LATERAL FLOW READERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)97
TABLE 24BENCHTOP LATERAL FLOW READERS MARKET, BY REGION, 2020–2027 (THOUSAND UNITS)97
6.4INSIGHTS ON DISPOSABLE AND REUSABLE LATERAL FLOW READERS98
6.5LATERAL FLOW READERS MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY TYPE98
6.5.1PRODUCT PORTFOLIO ANALYSIS OF LATERAL FLOW READERS FOR CLINICAL DIAGNOSTIC APPLICATIONS98
TABLE 25PRODUCT PORTFOLIO ANALYSIS OF LATERAL FLOW READERS FOR CLINICAL DIAGNOSTIC APPLICATIONS98
FIGURE 34PRODUCT PORTFOLIO ANALYSIS OF LATERAL FLOW READERS FOR CLINICAL DIAGNOSTICS (2021)100
7LATERAL FLOW ASSAYS MARKET, BY APPLICATION101
7.1INTRODUCTION102
TABLE 26LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)102
7.2CLINICAL TESTING102
TABLE 27LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2020–2027 (USD MILLION)103
TABLE 28LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY COUNTRY, 2020–2027 (USD MILLION)104
7.2.1INFECTIOUS DISEASE TESTING104
TABLE 29LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION)105
TABLE 30LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION)106
7.2.1.1Mosquito-borne diseases106
7.2.1.1.1Increasing incidence of dengue to support market growth106
TABLE 31DENGUE TESTING PRODUCTS AVAILABLE IN MARKET107
TABLE 32LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY COUNTRY, 2020–2027 (USD MILLION)108
7.2.1.2COVID-19109
7.2.1.2.1COVID-19 pandemic resulted in adoption of rapid lateral flow tests109
TABLE 33LATERAL FLOW ASSAY TESTS FOR COVID-19 (ANTIGEN AND ANTIBODY)109
TABLE 34LATERAL FLOW ASSAYS MARKET FOR COVID-19, BY COUNTRY, 2020–2027 (USD MILLION)110
7.2.1.3Influenza111
7.2.1.3.1Growing prevalence of influenza to support market growth111
TABLE 35LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY COUNTRY, 2020–2027 (USD MILLION)112
7.2.1.4Sexually transmitted infections112
TABLE 36LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION)113
TABLE 37LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2020–2027 (USD MILLION)114
7.2.1.4.1HIV114
7.2.1.4.1.1Growing awareness of HIV POC testing to drive market114
TABLE 38LATERAL FLOW ASSAYS MARKET FOR HIV, BY COUNTRY, 2020–2027 (USD MILLION)116
7.2.1.4.2HPV116
7.2.1.4.2.1Rising adoption of HPV testing to drive market during forecast period116
TABLE 39LATERAL FLOW ASSAYS MARKET FOR HPV, BY COUNTRY, 2020–2027 (USD MILLION)117
7.2.1.4.3Chlamydia117
7.2.1.4.3.1Growing incidence of chlamydia and rising awareness among patients to drive market117
TABLE 40LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY COUNTRY, 2020–2027 (USD MILLION)118
7.2.1.4.4Gonorrhea118
7.2.1.4.4.1Rising incidence of gonorrhea and increased funding for R&D to support market growth118
TABLE 41LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY COUNTRY, 2020–2027 (USD MILLION)119
7.2.1.4.5Syphilis120
7.2.1.4.5.1Growing adoption of novel technologies to support market growth120
TABLE 42LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY COUNTRY, 2020–2027 (USD MILLION)121
7.2.1.4.6Other sexually transmitted infections121
TABLE 43LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2020–2027 (USD MILLION)122
7.2.1.5Hepatitis122
7.2.1.5.1Nucleic acid hybridization-based lateral flow assays hold great potential in hepatitis testing market122
TABLE 44LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY COUNTRY, 2020–2027 (USD MILLION)123
7.2.1.6Tuberculosis123
7.2.1.6.1Rising prevalence and growing focus on early diagnosis and treatment to drive market123
TABLE 45LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY COUNTRY, 2020–2027 (USD MILLION)124
7.2.1.7Other infectious diseases124
TABLE 46LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2020–2027 (USD MILLION)125
7.2.2CARDIAC MARKER TESTING126
TABLE 47LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION)126
TABLE 48LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION)127
7.2.2.1Troponin I and T127
7.2.2.1.1Introduction of high-sensitivity troponin assays to drive market127
TABLE 49LATERAL FLOW ASSAYS MARKET FOR TROPONIN I AND T TESTING, BY COUNTRY, 2020–2027 (USD MILLION)128
7.2.2.2CK-MB128
7.2.2.2.1Growing applications of lateral flow tests in acute myocardial injuries to drive market128
TABLE 50LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY COUNTRY, 2020–2027 (USD MILLION)129
7.2.2.3BNP and NT-proBNP129
7.2.2.3.1Increasing demand for cardiac biomarker tests to detect heart stress and damage to propel adoption129
TABLE 51LATERAL FLOW ASSAYS MARKET FOR BNP AND NT-PROBNP TESTING, BY COUNTRY, 2020–2027 (USD MILLION)130
7.2.2.4Myoglobin130
7.2.2.4.1Availability of new high-sensitivity cardiac troponin assays to restrict market growth130
TABLE 52LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY COUNTRY, 2020–2027 (USD MILLION)131
7.2.2.5D-dimer131
7.2.2.5.1Rising incidence of cardiovascular diseases to drive market for D-dimer tests131
TABLE 53LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY COUNTRY, 2020–2027 (USD MILLION)132
7.2.2.6Other cardiac markers132
TABLE 54LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTS, BY COUNTRY, 2020–2027 (USD MILLION)133
7.2.3PREGNANCY AND FERTILITY TESTING133
TABLE 55LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION)134
TABLE 56LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION)135
7.2.3.1Pregnancy testing135
7.2.3.1.1Most common application area for lateral flow assays135
TABLE 57LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2020–2027 (USD MILLION)136
7.2.3.2Fertility testing136
7.2.3.2.1Rising infertility rates to drive demand for POC fertility testing kits136
TABLE 58LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION)137
7.2.4CHOLESTEROL/LIPID TESTING137
7.2.4.1Growing prevalence of obesity and CVD to drive market137
TABLE 59LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING, BY COUNTRY, 2020–2027 (USD MILLION)138
7.2.5DRUGS-OF-ABUSE TESTING138
7.2.5.1Technological advancements and growing focus on workplace drug testing to drive market138
TABLE 60LATERAL FLOW ASSAYS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION)139
7.2.6OTHER CLINICAL TESTS139
TABLE 61LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY, 2020–2027 (USD MILLION)140
7.3VETERINARY DIAGNOSTICS140
7.3.1INFECTIOUS DISEASE OUTBREAKS, PARTICULARLY IN LARGE LIVESTOCK ANIMALS, TO DRIVE MARKET140
TABLE 62LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)141
7.4FOOD SAFETY AND ENVIRONMENTAL TESTING142
7.4.1HIGH SENSITIVITY AND EASE OF USE SUPPORTING MARKET GROWTH142
TABLE 63LATERAL FLOW ASSAYS MARKET FOR FOOD SAFETY AND ENVIRONMENTAL TESTING, BY COUNTRY, 2020–2027 (USD MILLION)143
7.5DRUG DEVELOPMENT AND QUALITY TESTING143
7.5.1INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET143
TABLE 64LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT AND QUALITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION)144
8LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE145
8.1INTRODUCTION146
TABLE 65LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)146
TABLE 66LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)147
8.2SANDWICH ASSAYS147
8.2.1WIDE APPLICATIONS IN CLINICAL TESTING TO SUPPORT MARKET GROWTH147
TABLE 67LATERAL FLOW SANDWICH ASSAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)148
8.3COMPETITIVE ASSAYS149
8.3.1REDUCED SELECTIVITY AND SENSITIVITY IN RELATION TO SANDWICH ASSAYS TO HAMPER GROWTH149
TABLE 68LATERAL FLOW COMPETITIVE ASSAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)150
8.4MULTIPLEX DETECTION ASSAYS150
8.4.1INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET150
TABLE 69LATERAL FLOW MULTIPLEX DETECTION ASSAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)151
9LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE152
9.1INTRODUCTION153
TABLE 70LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION)153
9.2BLOOD SAMPLES153
9.2.1INCREASING USE OF BLOOD SAMPLES IN INFECTIOUS DISEASE TESTING TO DRIVE MARKET153
TABLE 71LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2020–2027 (USD MILLION)154
9.3URINE SAMPLES154
9.3.1GROWING USE OF URINE SAMPLES IN PREGNANCY AND DRUGS-OF-ABUSE TESTING TO DRIVE MARKET154
TABLE 72LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY COUNTRY, 2020–2027 (USD MILLION)155
9.4SALIVA SAMPLES155
9.4.1EASY AND LOW-COST COLLECTION, TRANSPORT, AND ANALYSIS OF SALIVA SAMPLES TO SUPPORT ADOPTION155
TABLE 73LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY COUNTRY, 2020–2027 (USD MILLION)156
9.5OTHER SAMPLES157
TABLE 74LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES, BY COUNTRY, 2020–2027 (USD MILLION)157
10LATERAL FLOW ASSAYS MARKET, BY END USER158
10.1INTRODUCTION159
TABLE 75LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)159
10.2HOSPITALS AND CLINICS159
10.2.1INCREASING USE OF POC TESTS TO DRIVE MARKET159
TABLE 76LATERAL FLOW ASSAYS MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2020–2027 (USD MILLION)160
10.3HOME CARE SETTINGS160
10.3.1GROWING ACCEPTANCE OF REMOTE MONITORING TO PROPEL MARKET160
TABLE 77LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2020–2027 (USD MILLION)161
10.4DIAGNOSTIC LABORATORIES162
10.4.1HIGH PREFERENCE FOR LABORATORY TESTING TO TEST URINE AND BLOOD SAMPLES TO SUPPORT MARKET GROWTH162
TABLE 78LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION)163
10.5PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES163
10.5.1INCREASING FOCUS ON PRODUCT SAFETY TO DRIVE ADOPTION OF LATERAL FLOW ASSAYS163
TABLE 79LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)164
10.6OTHER END USERS164
TABLE 80LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)165
11LATERAL FLOW ASSAYS MARKET, BY REGION166
11.1INTRODUCTION167
FIGURE 35CHINA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD167
TABLE 81LATERAL FLOW ASSAYS MARKET, BY REGION, 2020–2027 (USD MILLION)168
11.2NORTH AMERICA168
TABLE 82NORTH AMERICA: MACROECONOMIC INDICATORS169
FIGURE 36NORTH AMERICA: LATERAL FLOW ASSAYS MARKET SNAPSHOT169
TABLE 83NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)170
TABLE 84NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)170
TABLE 85NORTH AMERICA: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION)170
TABLE 86NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)171
TABLE 87NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)171
TABLE 88NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION)172
TABLE 89NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION)172
TABLE 90NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION)173
TABLE 91NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION)173
TABLE 92NORTH AMERICA: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)173
TABLE 93NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION)174
TABLE 94NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)174
11.2.1US174
11.2.1.1Largest market for lateral flow assays174
TABLE 95US: MACROECONOMIC INDICATORS175
TABLE 96US: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)175
TABLE 97US: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION)176
TABLE 98US: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)176
TABLE 99US: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)176
TABLE 100US: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION)177
TABLE 101US: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION)177
TABLE 102US: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION)178
TABLE 103US: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION)178
TABLE 104US: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)178
TABLE 105US: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION)179
TABLE 106US: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 USD MILLION)179
11.2.2CANADA179
11.2.2.1Availability of research funding and implementation of favorable government initiatives to drive market179
TABLE 107CANADA: MACROECONOMIC INDICATORS180
TABLE 108CANADA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)180
TABLE 109CANADA: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION)181
TABLE 110CANADA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)181
TABLE 111CANADA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)182
TABLE 112CANADA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION)182
TABLE 113CANADA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION)183
TABLE 114CANADA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION)183
TABLE 115CANADA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION)184
TABLE 116CANADA: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)184
TABLE 117CANADA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION)184
TABLE 118CANADA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 USD MILLION)185
11.2.3RECESSION IMPACT185
11.3EUROPE186
TABLE 119EUROPE: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)186
TABLE 120EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)186
TABLE 121EUROPE: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION)187
TABLE 122EUROPE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)187
TABLE 123EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)187
TABLE 124EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION)188
TABLE 125EUROPE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION)188
TABLE 126EUROPE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION)189
TABLE 127EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION)189
TABLE 128EUROPE: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)189
TABLE 129EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION)190
TABLE 130EUROPE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)190
11.3.1GERMANY190
11.3.1.1Growing number of POC diagnostic centers to drive demand for lateral flow assays190
TABLE 131GERMANY: MACROECONOMIC INDICATORS191
TABLE 132GERMANY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)191
TABLE 133GERMANY: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION)191
TABLE 134GERMANY: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)192
TABLE 135GERMANY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)192
TABLE 136GERMANY: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION)193
TABLE 137GERMANY: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION)193
TABLE 138GERMANY: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION)194
TABLE 139GERMANY: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION)194
TABLE 140GERMANY: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)194
TABLE 141GERMANY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION)195
TABLE 142GERMANY: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)195
11.3.2FRANCE196
11.3.2.1High prevalence of age-related chronic and infectious diseases to drive market196
TABLE 143FRANCE: MACROECONOMIC INDICATORS196
TABLE 144FRANCE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)196
TABLE 145FRANCE: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION)197
TABLE 146FRANCE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)197
TABLE 147FRANCE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)198
TABLE 148FRANCE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION)198
TABLE 149FRANCE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION)199
TABLE 150FRANCE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION)199
TABLE 151FRANCE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION)200
TABLE 152FRANCE: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)200
TABLE 153FRANCE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION)200
TABLE 154FRANCE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)201
11.3.3UK201
11.3.3.1Rising prevalence of obesity to propel market201
TABLE 155UK: MACROECONOMIC INDICATORS202
TABLE 156UK: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)202
TABLE 157UK: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION)202
TABLE 158UK: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)203
TABLE 159UK: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)203
TABLE 160UK: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION)204
TABLE 161UK: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION)204
TABLE 162UK: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION)205
TABLE 163UK: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION)205
TABLE 164UK: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)205
TABLE 165UK: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION)206
TABLE 166UK: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)206
11.3.4ITALY206
11.3.4.1Growing initiatives toward decentralization of medical services to support market growth206
TABLE 167ITALY: MACROECONOMIC INDICATORS207
TABLE 168ITALY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)207
TABLE 169ITALY: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION)207
TABLE 170ITALY: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)208
TABLE 171ITALY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)208
TABLE 172ITALY: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION)209
TABLE 173ITALY: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION)209
TABLE 174ITALY: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION)210
TABLE 175ITALY: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION)210
TABLE 176ITALY: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)210
TABLE 177ITALY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION)211
TABLE 178ITALY: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)211
11.3.5SPAIN211
11.3.5.1Increasing focus of international organizations and domestic players on development of POC products to aid market growth211
TABLE 179SPAIN: MACROECONOMIC INDICATORS212
TABLE 180SPAIN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)212
TABLE 181SPAIN: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION)212
TABLE 182SPAIN: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)213
TABLE 183SPAIN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)213
TABLE 184SPAIN: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION)214
TABLE 185SPAIN: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION)214
TABLE 186SPAIN: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION)215
TABLE 187SPAIN: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION)215
TABLE 188SPAIN: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)215
TABLE 189SPAIN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION)216
TABLE 190SPAIN: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)216
11.3.6REST OF EUROPE216
TABLE 191REST OF EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)217
TABLE 192REST OF EUROPE: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION)217
TABLE 193REST OF EUROPE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)217
TABLE 194REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)218
TABLE 195REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION)218
TABLE 196REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION)219
TABLE 197REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION)219
TABLE 198REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION)220
TABLE 199R
“Urine samples accounted for the third largest share of lateral flow assays market in 2021”
Based on sample type, the clinical testing lateral flow assays market is segmented into blood, urine, saliva, and other samples. Urine samples accounted for the third largest market share in 2021. The increasing use of urine samples in lateral flow tests for pregnancy, fertility testing, and drug of abuse testing.
“The Pharmaceutical & Biotechnology Companies segment is expected to witness the fastest growth during the forecast period”
Based on end users, the lateral flow assays market is segmented into hospitals & clinics, diagnostic laboratories, home care settings, pharmaceutical & biotechnology companies, and other end users. The pharmaceutical & biotechnology companies segment is expected to witness the fastest growth during the forecast period. This growth is owing to increasing adoption of lateral flow assay readers and kits & reagents for quantitative detection of sample in pharmaceutical & biotechnology companies.
“Asia-Pacific accounted for the second largest share of the lateral flow assays market in 2021”
The North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2021, Asia-Pacific accounted for the second largest share of the lateral flow assays market, followed by Europe, Latin America, and the Middle East & Africa. However, the North America is a leading region in the lateral flow assay market. Being a high-growth market, many manufacturers are also extending their manufacturing bases in the Asia Pacific, which boasts low-cost manufacturing advantages and the availability of a skilled workforce, especially in China and India.
These countries are also regarded as the most profitable manufacturing and R&D locations across the globe. The key factors hindering market growth in this region are a lack of awareness about the advantages of near-patient testing products due to low literacy rates, lack of reimbursements, challenges related to locational remoteness, and the reluctance of physicians to change existing practices.
A breakdown of the primary participants (supply-side) for the lateral flow assays market referred to for this report is provided below:
•By Company Type: Tier 1–35%, Tier 2–20%, and Tier 3–45%
•By Designation: C-level–45%, Director Level–25%, and Others–30%
•By Region: North America–36%, Europe–26%, Asia Pacific–21%, Latin America- 10%, and Middle East and Africa– 7%
Some of the key players in the Lateral flow assays market are Abbott Laboratories (US), F. Hoffman-La Roche AG (Switzerland), Danaher Corporation (US), Siemens AG (Germany), BD (US), bioMérieux SA (France), Thermo Fisher Scientific, Inc. (US), PerkinElmer Inc. (US), Hologic Inc. (US), QIAGEN N.V. (Netherlands), Quidel Corporation (US), and Merck KGaA (Germany).
Research Coverage:
The market study covers the lateral flow assays market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by product type, application by technique, by sample type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the lateral flow assays market and its segments. This report will help stakeholders understand the competitive landscape, gain insights to position their businesses better, and plan suitable go-to-market strategies. The report will also help stakeholders in understanding the pulse of the market and gaining information on key market drivers, restraints, opportunities, and challenges.
1INTRODUCTION32
1.1STUDY OBJECTIVES32
1.2MARKET DEFINITION32
1.2.1INCLUSIONS AND EXCLUSIONS33
1.3MARKET SCOPE34
1.3.1MARKETS COVERED34
FIGURE 1LATERAL FLOW ASSAYS MARKET SEGMENTATION34
FIGURE 2REGIONAL SCOPE35
1.3.2YEARS CONSIDERED35
1.4CURRENCY CONSIDERED35
TABLE 1EXCHANGE RATES UTILIZED FOR CONVERSION TO USD36
1.5STAKEHOLDERS36
1.6SUMMARY OF CHANGES36
1.6.1RECESSION IMPACT37
2RESEARCH METHODOLOGY38
2.1RESEARCH APPROACH38
FIGURE 3RESEARCH DESIGN38
2.1.1SECONDARY DATA38
2.1.1.1Key data from secondary sources39
2.1.2PRIMARY DATA40
2.1.2.1Primary sources40
2.1.2.2Key data from primary sources41
2.1.2.3Breakdown of primaries41
FIGURE 4BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION41
2.2MARKET SIZE ESTIMATION42
FIGURE 5MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021)43
FIGURE 6SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAYS MARKET (2021)43
FIGURE 7APPROACH 3: DEMAND-SIDE APPROACH, BASED ON MALARIA LATERAL FLOW TESTING MARKET SIZE (2021)44
FIGURE 8TOP-DOWN APPROACH44
FIGURE 9DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022–2027): IMPACT ON MARKET GROWTH AND CAGR46
FIGURE 10CAGR PROJECTIONS46
2.3MARKET BREAKDOWN AND DATA TRIANGULATION47
FIGURE 11DATA TRIANGULATION METHODOLOGY48
2.4KEY INDUSTRY INSIGHTS49
2.5LIMITATIONS49
2.5.1METHODOLOGY-RELATED LIMITATIONS49
2.6RISK ASSESSMENT50
2.7STUDY ASSUMPTIONS50
2.8RECESSION IMPACT51
3EXECUTIVE SUMMARY52
FIGURE 12LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)52
FIGURE 13LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION)53
FIGURE 14LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)53
FIGURE 15LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2022 VS. 2027 (USD MILLION)54
FIGURE 16LATERAL FLOW ASSAYS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)55
FIGURE 17GEOGRAPHIC SNAPSHOT OF LATERAL FLOW ASSAYS MARKET56
4PREMIUM INSIGHTS57
4.1LATERAL FLOW ASSAYS MARKET OVERVIEW57
FIGURE 18HIGH PREVALENCE OF INFECTIOUS DISEASES TO DRIVE MARKET57
4.2REGIONAL MIX: LATERAL FLOW ASSAYS MARKET57
FIGURE 19ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD57
4.3ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION AND COUNTRY (2021)58
FIGURE 20CLINICAL TESTING SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 202158
4.4LATERAL FLOW ASSAYS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES59
FIGURE 21CHINA TO REGISTER HIGHEST GROWTH IN FORECAST PERIOD59
4.5LATERAL FLOW ASSAYS MARKET: DEVELOPING VS. DEVELOPED COUNTRIES60
FIGURE 22DEVELOPING COUNTRIES TO OFFER HIGH GROWTH OPPORTUNITIES IN FORECAST PERIOD60
5MARKET OVERVIEW61
5.1INTRODUCTION61
5.2MARKET DYNAMICS61
FIGURE 23LATERAL FLOW ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES61
5.2.1DRIVERS62
5.2.1.1High prevalence of infectious diseases62
TABLE 2PREVALENCE OF HIV WORLDWIDE (2017 VS. 2021)62
5.2.1.2Rapidly increasing geriatric population63
FIGURE 24GERIATRIC POPULATION, BY REGION, 2020 VS. 2050 (MILLION)63
FIGURE 25GERIATRIC POPULATION, BY REGION, 2022 VS. 2030 VS. 2050 (% OF TOTAL POPULATION)64
5.2.1.3Growing use of home-based lateral flow assay devices64
5.2.1.4Growing demand for point-of-care testing65
5.2.1.5Need for rapid diagnostic testing for COVID-1965
5.2.2RESTRAINTS66
5.2.2.1Inconsistent results of lateral flow assay tests66
5.2.3OPPORTUNITIES66
5.2.3.1Evolving applications of lateral flow assays66
TABLE 3LIST OF COMMERCIALLY AVAILABLE SALIVA LFA PRODUCTS67
5.2.3.2Rising demand for lateral flow assays in food & beverage industry67
5.2.3.3Omicron offers growth opportunities for players in lateral flow assays market68
TABLE 4EPIDEMIOLOGICAL UPDATE ON OMICRON VARIANT68
TABLE 5EXAMPLES OF LATERAL FLOW ASSAY KITS AVAILABLE FOR DETECTION OF OMICRON68
5.2.4CHALLENGES69
5.2.4.1Limited reimbursements for lateral flow assay products69
5.2.4.2Difficulties in procuring quality raw materials for development of lateral flow assay tests70
5.3COVID-19 IMPACT ASSESSMENT ON ECONOMIC SCENARIO70
5.4TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS70
FIGURE 26TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS71
5.5AVERAGE SELLING PRICE TREND71
5.5.1AVERAGE SELLING PRICES OF KEY PLAYERS, BY APPLICATION71
TABLE 6AVERAGE SELLING PRICE OF LATERAL FLOW ASSAYS (KITS AND REAGENTS)71
5.5.2AVERAGE SELLING PRICE TRENDS72
TABLE 7AVERAGE SELLING PRICE OF LATERAL FLOW ANALYZERS, BY REGION, 2020 VS. 202172
5.6ECOSYSTEM MARKET MAP72
FIGURE 27LATERAL FLOW ASSAYS MARKET: ECOSYSTEM ANALYSIS (2021)73
5.7PATENT ANALYSIS74
5.7.1PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS74
FIGURE 28GLOBAL PATENT PUBLICATION TRENDS IN LATERAL FLOW ASSAYS MARKET, 2016–202274
5.7.2TOP APPLICANTS (COMPANIES) OF LATERAL FLOW ASSAY PATENTS75
FIGURE 29TOP COMPANIES THAT APPLIED FOR LATERAL FLOW ASSAY PATENTS, 2016–202275
5.7.3JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN LATERAL FLOW ASSAYS MARKET75
FIGURE 30JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAY PATENTS, 2016–202275
5.8VALUE CHAIN ANALYSIS76
FIGURE 31LATERAL FLOW ASSAYS MARKET: VALUE CHAIN ANALYSIS (2021)76
5.9TECHNOLOGY ANALYSIS76
5.9.1KEY TECHNOLOGY: LATERAL FLOW ASSAYS76
5.9.2ADJACENT TECHNOLOGY: ENZYME-LINKED IMMUNOSORBENT ASSAYS77
5.10CASE STUDY ANALYSIS77
5.11REGULATORY ANALYSIS78
5.11.1REGULATORY LANDSCAPE78
5.11.1.1North America78
5.11.1.2Europe78
5.11.1.3Asia79
5.11.1.3.1India79
5.11.1.3.2China79
5.11.1.3.3Japan79
5.11.2REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS80
TABLE 8REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY BY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS80
5.12PORTER’S FIVE FORCES ANALYSIS80
TABLE 9LATERAL FLOW ASSAYS MARKET: PORTER’S FIVE FORCES ANALYSIS80
5.12.1THREAT OF NEW ENTRANTS81
5.12.2THREAT OF SUBSTITUTES81
5.12.3BARGAINING POWER OF SUPPLIERS82
5.12.4BARGAINING POWER OF BUYERS82
5.12.5INTENSITY OF COMPETITIVE RIVALRY82
5.13ADJACENT MARKET ANALYSIS82
5.14KEY CONFERENCES AND EVENTS DURING 2023–202483
TABLE 10LATERAL FLOW ASSAYS MARKET: DETAILED LIST OF CONFERENCES & EVENTS83
5.15KEY STAKEHOLDERS AND BUYING CRITERIA84
5.15.1KEY STAKEHOLDERS IN BUYING PROCESS84
FIGURE 32INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS84
TABLE 11INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS84
5.15.2BUYING CRITERIA84
FIGURE 33KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS84
5.16TRADE ANALYSIS85
5.17INDUSTRY TRENDS85
5.17.1DETECTION OF HIV WITH LATERAL FLOW ASSAYS85
TABLE 12US: HIV PREVALENCE RATE, 2016–202085
5.17.2INCREASING ADOPTION OF QUANTITATIVE LATERAL FLOW ASSAYS DUE TO AVAILABILITY OF LFA READERS86
5.18IMPACT OF INFLATION AND RECESSION ON LATERAL FLOW ASSAYS MARKET86
6LATERAL FLOW ASSAYS MARKET, BY PRODUCT88
6.1INTRODUCTION89
TABLE 13LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)89
6.2KITS AND REAGENTS89
6.2.1INCREASING DEMAND FOR POC TESTING TO DRIVE MARKET89
TABLE 14LATERAL FLOW KITS AND REAGENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)90
6.3LATERAL FLOW READERS90
TABLE 15EXAMPLES OF LATERAL FLOW READERS AVAILABLE IN MARKET91
TABLE 16LATERAL FLOW ASSAY KITS AND REAGENTS WITH AND WITHOUT ANALYZERS92
TABLE 17LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION)93
TABLE 18LATERAL FLOW READERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)93
TABLE 19LATERAL FLOW READERS MARKET, BY END USER, 2020–2027 (USD MILLION)93
TABLE 20LATERAL FLOW READERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)94
6.3.1DIGITAL/HANDHELD READERS94
6.3.1.1Technological advancements and high accuracy—major factors driving market94
TABLE 21DIGITAL/HANDHELD LATERAL FLOW READERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)95
TABLE 22DIGITAL/HANDHELD LATERAL FLOW READERS MARKET, BY REGION, 2020–2027 (THOUSAND UNITS)96
6.3.2BENCHTOP READERS96
6.3.2.1Lower diagnosis cost per patient to drive adoption96
TABLE 23BENCHTOP LATERAL FLOW READERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)97
TABLE 24BENCHTOP LATERAL FLOW READERS MARKET, BY REGION, 2020–2027 (THOUSAND UNITS)97
6.4INSIGHTS ON DISPOSABLE AND REUSABLE LATERAL FLOW READERS98
6.5LATERAL FLOW READERS MARKET FOR CLINICAL DIAGNOSTIC APPLICATIONS, BY TYPE98
6.5.1PRODUCT PORTFOLIO ANALYSIS OF LATERAL FLOW READERS FOR CLINICAL DIAGNOSTIC APPLICATIONS98
TABLE 25PRODUCT PORTFOLIO ANALYSIS OF LATERAL FLOW READERS FOR CLINICAL DIAGNOSTIC APPLICATIONS98
FIGURE 34PRODUCT PORTFOLIO ANALYSIS OF LATERAL FLOW READERS FOR CLINICAL DIAGNOSTICS (2021)100
7LATERAL FLOW ASSAYS MARKET, BY APPLICATION101
7.1INTRODUCTION102
TABLE 26LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)102
7.2CLINICAL TESTING102
TABLE 27LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2020–2027 (USD MILLION)103
TABLE 28LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY COUNTRY, 2020–2027 (USD MILLION)104
7.2.1INFECTIOUS DISEASE TESTING104
TABLE 29LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION)105
TABLE 30LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION)106
7.2.1.1Mosquito-borne diseases106
7.2.1.1.1Increasing incidence of dengue to support market growth106
TABLE 31DENGUE TESTING PRODUCTS AVAILABLE IN MARKET107
TABLE 32LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY COUNTRY, 2020–2027 (USD MILLION)108
7.2.1.2COVID-19109
7.2.1.2.1COVID-19 pandemic resulted in adoption of rapid lateral flow tests109
TABLE 33LATERAL FLOW ASSAY TESTS FOR COVID-19 (ANTIGEN AND ANTIBODY)109
TABLE 34LATERAL FLOW ASSAYS MARKET FOR COVID-19, BY COUNTRY, 2020–2027 (USD MILLION)110
7.2.1.3Influenza111
7.2.1.3.1Growing prevalence of influenza to support market growth111
TABLE 35LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY COUNTRY, 2020–2027 (USD MILLION)112
7.2.1.4Sexually transmitted infections112
TABLE 36LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION)113
TABLE 37LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2020–2027 (USD MILLION)114
7.2.1.4.1HIV114
7.2.1.4.1.1Growing awareness of HIV POC testing to drive market114
TABLE 38LATERAL FLOW ASSAYS MARKET FOR HIV, BY COUNTRY, 2020–2027 (USD MILLION)116
7.2.1.4.2HPV116
7.2.1.4.2.1Rising adoption of HPV testing to drive market during forecast period116
TABLE 39LATERAL FLOW ASSAYS MARKET FOR HPV, BY COUNTRY, 2020–2027 (USD MILLION)117
7.2.1.4.3Chlamydia117
7.2.1.4.3.1Growing incidence of chlamydia and rising awareness among patients to drive market117
TABLE 40LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY COUNTRY, 2020–2027 (USD MILLION)118
7.2.1.4.4Gonorrhea118
7.2.1.4.4.1Rising incidence of gonorrhea and increased funding for R&D to support market growth118
TABLE 41LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY COUNTRY, 2020–2027 (USD MILLION)119
7.2.1.4.5Syphilis120
7.2.1.4.5.1Growing adoption of novel technologies to support market growth120
TABLE 42LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY COUNTRY, 2020–2027 (USD MILLION)121
7.2.1.4.6Other sexually transmitted infections121
TABLE 43LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2020–2027 (USD MILLION)122
7.2.1.5Hepatitis122
7.2.1.5.1Nucleic acid hybridization-based lateral flow assays hold great potential in hepatitis testing market122
TABLE 44LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY COUNTRY, 2020–2027 (USD MILLION)123
7.2.1.6Tuberculosis123
7.2.1.6.1Rising prevalence and growing focus on early diagnosis and treatment to drive market123
TABLE 45LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY COUNTRY, 2020–2027 (USD MILLION)124
7.2.1.7Other infectious diseases124
TABLE 46LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2020–2027 (USD MILLION)125
7.2.2CARDIAC MARKER TESTING126
TABLE 47LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION)126
TABLE 48LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION)127
7.2.2.1Troponin I and T127
7.2.2.1.1Introduction of high-sensitivity troponin assays to drive market127
TABLE 49LATERAL FLOW ASSAYS MARKET FOR TROPONIN I AND T TESTING, BY COUNTRY, 2020–2027 (USD MILLION)128
7.2.2.2CK-MB128
7.2.2.2.1Growing applications of lateral flow tests in acute myocardial injuries to drive market128
TABLE 50LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY COUNTRY, 2020–2027 (USD MILLION)129
7.2.2.3BNP and NT-proBNP129
7.2.2.3.1Increasing demand for cardiac biomarker tests to detect heart stress and damage to propel adoption129
TABLE 51LATERAL FLOW ASSAYS MARKET FOR BNP AND NT-PROBNP TESTING, BY COUNTRY, 2020–2027 (USD MILLION)130
7.2.2.4Myoglobin130
7.2.2.4.1Availability of new high-sensitivity cardiac troponin assays to restrict market growth130
TABLE 52LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY COUNTRY, 2020–2027 (USD MILLION)131
7.2.2.5D-dimer131
7.2.2.5.1Rising incidence of cardiovascular diseases to drive market for D-dimer tests131
TABLE 53LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY COUNTRY, 2020–2027 (USD MILLION)132
7.2.2.6Other cardiac markers132
TABLE 54LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTS, BY COUNTRY, 2020–2027 (USD MILLION)133
7.2.3PREGNANCY AND FERTILITY TESTING133
TABLE 55LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION)134
TABLE 56LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION)135
7.2.3.1Pregnancy testing135
7.2.3.1.1Most common application area for lateral flow assays135
TABLE 57LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2020–2027 (USD MILLION)136
7.2.3.2Fertility testing136
7.2.3.2.1Rising infertility rates to drive demand for POC fertility testing kits136
TABLE 58LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION)137
7.2.4CHOLESTEROL/LIPID TESTING137
7.2.4.1Growing prevalence of obesity and CVD to drive market137
TABLE 59LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING, BY COUNTRY, 2020–2027 (USD MILLION)138
7.2.5DRUGS-OF-ABUSE TESTING138
7.2.5.1Technological advancements and growing focus on workplace drug testing to drive market138
TABLE 60LATERAL FLOW ASSAYS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION)139
7.2.6OTHER CLINICAL TESTS139
TABLE 61LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY, 2020–2027 (USD MILLION)140
7.3VETERINARY DIAGNOSTICS140
7.3.1INFECTIOUS DISEASE OUTBREAKS, PARTICULARLY IN LARGE LIVESTOCK ANIMALS, TO DRIVE MARKET140
TABLE 62LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)141
7.4FOOD SAFETY AND ENVIRONMENTAL TESTING142
7.4.1HIGH SENSITIVITY AND EASE OF USE SUPPORTING MARKET GROWTH142
TABLE 63LATERAL FLOW ASSAYS MARKET FOR FOOD SAFETY AND ENVIRONMENTAL TESTING, BY COUNTRY, 2020–2027 (USD MILLION)143
7.5DRUG DEVELOPMENT AND QUALITY TESTING143
7.5.1INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET143
TABLE 64LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT AND QUALITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION)144
8LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE145
8.1INTRODUCTION146
TABLE 65LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)146
TABLE 66LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)147
8.2SANDWICH ASSAYS147
8.2.1WIDE APPLICATIONS IN CLINICAL TESTING TO SUPPORT MARKET GROWTH147
TABLE 67LATERAL FLOW SANDWICH ASSAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)148
8.3COMPETITIVE ASSAYS149
8.3.1REDUCED SELECTIVITY AND SENSITIVITY IN RELATION TO SANDWICH ASSAYS TO HAMPER GROWTH149
TABLE 68LATERAL FLOW COMPETITIVE ASSAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)150
8.4MULTIPLEX DETECTION ASSAYS150
8.4.1INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET150
TABLE 69LATERAL FLOW MULTIPLEX DETECTION ASSAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)151
9LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE152
9.1INTRODUCTION153
TABLE 70LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION)153
9.2BLOOD SAMPLES153
9.2.1INCREASING USE OF BLOOD SAMPLES IN INFECTIOUS DISEASE TESTING TO DRIVE MARKET153
TABLE 71LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2020–2027 (USD MILLION)154
9.3URINE SAMPLES154
9.3.1GROWING USE OF URINE SAMPLES IN PREGNANCY AND DRUGS-OF-ABUSE TESTING TO DRIVE MARKET154
TABLE 72LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY COUNTRY, 2020–2027 (USD MILLION)155
9.4SALIVA SAMPLES155
9.4.1EASY AND LOW-COST COLLECTION, TRANSPORT, AND ANALYSIS OF SALIVA SAMPLES TO SUPPORT ADOPTION155
TABLE 73LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY COUNTRY, 2020–2027 (USD MILLION)156
9.5OTHER SAMPLES157
TABLE 74LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES, BY COUNTRY, 2020–2027 (USD MILLION)157
10LATERAL FLOW ASSAYS MARKET, BY END USER158
10.1INTRODUCTION159
TABLE 75LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)159
10.2HOSPITALS AND CLINICS159
10.2.1INCREASING USE OF POC TESTS TO DRIVE MARKET159
TABLE 76LATERAL FLOW ASSAYS MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2020–2027 (USD MILLION)160
10.3HOME CARE SETTINGS160
10.3.1GROWING ACCEPTANCE OF REMOTE MONITORING TO PROPEL MARKET160
TABLE 77LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2020–2027 (USD MILLION)161
10.4DIAGNOSTIC LABORATORIES162
10.4.1HIGH PREFERENCE FOR LABORATORY TESTING TO TEST URINE AND BLOOD SAMPLES TO SUPPORT MARKET GROWTH162
TABLE 78LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION)163
10.5PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES163
10.5.1INCREASING FOCUS ON PRODUCT SAFETY TO DRIVE ADOPTION OF LATERAL FLOW ASSAYS163
TABLE 79LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)164
10.6OTHER END USERS164
TABLE 80LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)165
11LATERAL FLOW ASSAYS MARKET, BY REGION166
11.1INTRODUCTION167
FIGURE 35CHINA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD167
TABLE 81LATERAL FLOW ASSAYS MARKET, BY REGION, 2020–2027 (USD MILLION)168
11.2NORTH AMERICA168
TABLE 82NORTH AMERICA: MACROECONOMIC INDICATORS169
FIGURE 36NORTH AMERICA: LATERAL FLOW ASSAYS MARKET SNAPSHOT169
TABLE 83NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)170
TABLE 84NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)170
TABLE 85NORTH AMERICA: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION)170
TABLE 86NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)171
TABLE 87NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)171
TABLE 88NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION)172
TABLE 89NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION)172
TABLE 90NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION)173
TABLE 91NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION)173
TABLE 92NORTH AMERICA: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)173
TABLE 93NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION)174
TABLE 94NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)174
11.2.1US174
11.2.1.1Largest market for lateral flow assays174
TABLE 95US: MACROECONOMIC INDICATORS175
TABLE 96US: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)175
TABLE 97US: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION)176
TABLE 98US: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)176
TABLE 99US: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)176
TABLE 100US: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION)177
TABLE 101US: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION)177
TABLE 102US: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION)178
TABLE 103US: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION)178
TABLE 104US: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)178
TABLE 105US: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION)179
TABLE 106US: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 USD MILLION)179
11.2.2CANADA179
11.2.2.1Availability of research funding and implementation of favorable government initiatives to drive market179
TABLE 107CANADA: MACROECONOMIC INDICATORS180
TABLE 108CANADA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)180
TABLE 109CANADA: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION)181
TABLE 110CANADA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)181
TABLE 111CANADA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)182
TABLE 112CANADA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION)182
TABLE 113CANADA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION)183
TABLE 114CANADA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION)183
TABLE 115CANADA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION)184
TABLE 116CANADA: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)184
TABLE 117CANADA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION)184
TABLE 118CANADA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 USD MILLION)185
11.2.3RECESSION IMPACT185
11.3EUROPE186
TABLE 119EUROPE: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)186
TABLE 120EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)186
TABLE 121EUROPE: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION)187
TABLE 122EUROPE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)187
TABLE 123EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)187
TABLE 124EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION)188
TABLE 125EUROPE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION)188
TABLE 126EUROPE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION)189
TABLE 127EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION)189
TABLE 128EUROPE: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)189
TABLE 129EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION)190
TABLE 130EUROPE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)190
11.3.1GERMANY190
11.3.1.1Growing number of POC diagnostic centers to drive demand for lateral flow assays190
TABLE 131GERMANY: MACROECONOMIC INDICATORS191
TABLE 132GERMANY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)191
TABLE 133GERMANY: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION)191
TABLE 134GERMANY: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)192
TABLE 135GERMANY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)192
TABLE 136GERMANY: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION)193
TABLE 137GERMANY: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION)193
TABLE 138GERMANY: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION)194
TABLE 139GERMANY: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION)194
TABLE 140GERMANY: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)194
TABLE 141GERMANY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION)195
TABLE 142GERMANY: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)195
11.3.2FRANCE196
11.3.2.1High prevalence of age-related chronic and infectious diseases to drive market196
TABLE 143FRANCE: MACROECONOMIC INDICATORS196
TABLE 144FRANCE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)196
TABLE 145FRANCE: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION)197
TABLE 146FRANCE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)197
TABLE 147FRANCE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)198
TABLE 148FRANCE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION)198
TABLE 149FRANCE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION)199
TABLE 150FRANCE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION)199
TABLE 151FRANCE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION)200
TABLE 152FRANCE: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)200
TABLE 153FRANCE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION)200
TABLE 154FRANCE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)201
11.3.3UK201
11.3.3.1Rising prevalence of obesity to propel market201
TABLE 155UK: MACROECONOMIC INDICATORS202
TABLE 156UK: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)202
TABLE 157UK: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION)202
TABLE 158UK: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)203
TABLE 159UK: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)203
TABLE 160UK: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION)204
TABLE 161UK: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION)204
TABLE 162UK: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION)205
TABLE 163UK: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION)205
TABLE 164UK: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)205
TABLE 165UK: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION)206
TABLE 166UK: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)206
11.3.4ITALY206
11.3.4.1Growing initiatives toward decentralization of medical services to support market growth206
TABLE 167ITALY: MACROECONOMIC INDICATORS207
TABLE 168ITALY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)207
TABLE 169ITALY: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION)207
TABLE 170ITALY: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)208
TABLE 171ITALY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)208
TABLE 172ITALY: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION)209
TABLE 173ITALY: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION)209
TABLE 174ITALY: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION)210
TABLE 175ITALY: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION)210
TABLE 176ITALY: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)210
TABLE 177ITALY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION)211
TABLE 178ITALY: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)211
11.3.5SPAIN211
11.3.5.1Increasing focus of international organizations and domestic players on development of POC products to aid market growth211
TABLE 179SPAIN: MACROECONOMIC INDICATORS212
TABLE 180SPAIN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)212
TABLE 181SPAIN: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION)212
TABLE 182SPAIN: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)213
TABLE 183SPAIN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)213
TABLE 184SPAIN: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION)214
TABLE 185SPAIN: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION)214
TABLE 186SPAIN: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION)215
TABLE 187SPAIN: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION)215
TABLE 188SPAIN: LATERAL FLOW ASSAY KITS AND REAGENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)215
TABLE 189SPAIN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2020–2027 (USD MILLION)216
TABLE 190SPAIN: LATERAL FLOW ASSAYS MARKET, BY END USER, 2020–2027 (USD MILLION)216
11.3.6REST OF EUROPE216
TABLE 191REST OF EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)217
TABLE 192REST OF EUROPE: LATERAL FLOW READERS MARKET, BY TYPE, 2020–2027 (USD MILLION)217
TABLE 193REST OF EUROPE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)217
TABLE 194REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)218
TABLE 195REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY TYPE, 2020–2027 (USD MILLION)218
TABLE 196REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2020–2027 (USD MILLION)219
TABLE 197REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2027 (USD MILLION)219
TABLE 198REST OF EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY AND FERTILITY TESTING, BY TYPE, 2020–2027 (USD MILLION)220
TABLE 199R
Related Report
